Teva feels its present and its recent past will be “valued far more than the distant past,” as its leader admitted the company was continuing to battle to regain “credibility” following years of stagnation and decline.
Appearing at the recent Sidley Healthcare Investment Conference 2024 in central London, the Israeli firm’s CEO, Richard Francis, was asked...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?